詳細(xì)信息
- ;立克秀;1-(4-氯苯基)-4,4-二甲基-3(1H-1,2,4-三唑-1-基甲基)戊-3-醇;立克莠;(RS)-1-(4-氯苯基)-4,4-二甲基-3-(1H-1,2,4三唑-1-基甲基)戊-3-醇;(RS)-1-(4-氯苯基)-4,4-二甲基-3-(1H-1-1,2,4-三唑基甲基)戊醇-3;(RS)-1-(4-氯苯基)-4,4-二甲基-3-(1H-1,2,4-三唑-1-基甲基)戊-3-醇;(RS)-1-對(duì)-氯苯基-4,4-二甲基-3(1H-1,2,4-三唑-1-基甲基)戊醇
- Tebuconazole
- ;1,2,4-Triazole-1-ethanol, alpha-(2-(4-chlorophenyl)ethyl)-alpha-(1,1-dimethylethyl)-, (+-),;alpha-(2-(4-chlorophenyl)ethyl)-alpha-(1,1-dimethylethyl)-1H-1,2,4-triazol-1-ethanol, (+-)-;Elite;Folicur;Folicur 1.2 EC;GWG 1609;HWG 1608;Lynx;LYNX 1.2;Raxil;1-(4-chlorphenyl)-4,4-dimethyl-3-(1H-1,2,4-triazole-1-methyl)amyl-3-alcohol;Horizon;(RS)-1-(4-chlorophenyl)-4,4-dimethyl-3-(,2,4-triazol-1-yl)-1-3-ol;(RS)-1-p-chlorophenyl-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol;Tebuconazol;1-(4-Chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazole-1-yl-methyl)pentane-3-ol;Lynx Raxil;Silvacur;(RS)-1 -(4-chlorophenyl)-4,4-dimethyl-3-(1H-1,2,4-triazol-l-ylmethyl)pentan-3-ol;(+/-)-alpha-(2-(4-chlorophenyl)ethyl)-alpha-(1,1-dimethylethyl)-1H-1,2,4-triazol-1-ethanol;1-(4-chlorophenyl)-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol;2-[2-(4-chlorophenyl)ethyl]-3,3-dimethyl-2-(1H-1,2,4-triazol-1-yl)butan-1-ol;
- InChI=1/C16H22ClN3O/c1-15(2,3)16(10-21,20-12-18-11-19-20)9-8-13-4-6-14(17)7-5-13/h4-7,11-12,21H,8-10H2,1-3H3
- 1.14g/cm3
- 102.4℃
- 475.4°C at 760 mmHg
- 241.3°C
- 32 mg/L at 20℃
熔點(diǎn) 102.4°C
水溶性 32 mg/L at 20°C- CAS NO：107534-96-3
免責(zé)聲明：以上所展示的信息由企業(yè)自行提供，內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布企業(yè)負(fù)責(zé)，化工網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。我們?cè)瓌t上建議您選擇化工網(wǎng)高級(jí)會(huì)員或VIP會(huì)員。